Monomer Compositions for the Synthesis of RNA, Methods of Synthesis, and Methods of Deprotection
申请人:Agilent Technologies, Inc.
公开号:EP2567964A2
公开(公告)日:2013-03-13
2'-O protected nucleotide monomers for the synthesis of RNA.
用于合成 RNA 的 2'-O 保护核苷酸单体。
MONOMER COMPOSITIONS FOR THE SYNTHESIS OF RNA, METHODS OF SYNTHESIS, AND METHODS OF DEPROTECTION
申请人:Agilent Technologies, Inc.
公开号:EP2001896A2
公开(公告)日:2008-12-17
PARTICLES FOR MULTIPLE AGENT DELIVERY
申请人:Brigham and Women's Hospital, Inc.
公开号:EP2512522A2
公开(公告)日:2012-10-24
PARTICLES WITH MULTIPLE FUNCTIONALIZED SURFACE DOMAINS
申请人:Farokhzad Omid C.
公开号:US20120156135A1
公开(公告)日:2012-06-21
This disclosure relates to particles (e.g., nanoparticles and microparticles) that display multiple functionalized surface domains in a controlled mosaic pattern. The disclosure also provides simple methods to create various particles that have multiple functionalized surface domains while allowing the use of a wide variety of diverse core structures. The multiple functionalized domains provide controllable particle binding and orientation, and controlled and sustained drug release profiles.
Nanoparticles For Targeted Delivery of Multiple Therapeutic Agents and Methods of Use
申请人:The Brigham and Women's Hospital, Inc.
公开号:US20150265716A1
公开(公告)日:2015-09-24
Provided herein are compositions that contain a nanoparticle containing a plurality of polymers, wherein at least a fraction of the polymers comprise a hydrophobic polymer, a topoisomerase inhibitor, and a Pt-containing chemotherapeutic agent, where the polymers self-assemble in an aqueous liquid to form the nanoparticle, and where the Pt-containing chemotherapeutic agent and the topoisomerase inhibitor are present within the hydrophobic core of the nanoparticle in a ratio of between about 24:1 to about 1:24. Also provided are methods of reducing the proliferation of a cancer cell and methods of treating cancer in a subject that include the use of these compositions. Also provided are methods of making these nanoparticles.